For research use only. Not for therapeutic Use.
CL-82198(Cat No.:I003085) is a selective MMP-13 inhibitor. CL-82198 binds to the entire S1′ pocket of MMP-13, which is the basis for its selectivity for MMP-13 and lack of inhibitory activity against other MMPs. CL-82198 can be used in the research of osteoarthritis (OA).
Catalog Number | I003085 |
CAS Number | 307002-71-7 |
Synonyms | N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide;hydrochloride |
Molecular Formula | C17H23ClN2O3 |
Purity | ≥95% |
Target | MMP |
Solubility | DMSO ≥ 35 mg/mL |
Storage | 2-8°C |
IUPAC Name | N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide;hydrochloride |
InChI | InChI=1S/C17H22N2O3.ClH/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19;/h1-2,5-6,13H,3-4,7-12H2,(H,18,20);1H |
InChIKey | PIOACXKZWXHBRB-UHFFFAOYSA-N |
SMILES | C1COCCN1CCCCNC(=O)C2=CC3=CC=CC=C3O2.Cl |
Reference | <p style=/line-height:25px/> <br>[2]. Wohlauer M et al. Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Crit Care Med. 2012 Sep;40(9):2647-53. </p> |